Compare Fortune Mate Indonesia Tbk (FMII) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fortune Mate Indonesia Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Fortune Mate Indonesia Tbk trades at Rp252 (market cap 1.59T, 142.4K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: Fortune Mate Indonesia Tbk is far larger — about 2.7× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (817.3K versus 142.4K). Which is the better fit depends on your goals.
| FMII | LABS | |
|---|---|---|
Market Cap | 1.59T | 584.6B |
Volume | 142.4K | 817.3K |
Lot | 1.42K | 8.17K |
Turnover | 35.31M | 120.01M |
Average Price | 247.99 | 146.84 |
Value | 35.31M | 120.01M |
Indicative Equilibrium Price | 252 | 146 |
Indicative Equilibrium Volume | 33 | 59 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fortune Mate Indonesia Tbk
PT Fortune Mate Indonesia Tbk (the Entity) was established within the framework of the Foreign Capital Investment Law (PMA) No. 1 year 1967 based on Notarial Deed No. 44 dated June 24, 1989 by Rika You Soo Shin, S.H., notary in Surabaya. The Entity has started its commercial operations since 1989 comprises the manufacturing of footwear were located in Sidoarjo, East Java and stopped its operation since middle of March 2004. The Entity's office and real estate are located in Surabaya.
Read more on FMII →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
